The latest round includes a primary capital infusion of $250 million and a secondary sale of around $33 million by select angels and a few seed-stage investors, the company said.from Tech-Economic Times https://ift.tt/3Dupbla
The latest round includes a primary capital infusion of $250 million and a secondary sale of around $33 million by select angels and a few seed-stage investors, the company said.from Tech-Economic Times https://ift.tt/3Dupbla
No comments:
Post a Comment